Zydus Cadila Completes Acquisition Of Simayla

Indian drugmaker Zydus Cadila acquired the remaining 30% stake of South Africa's Simayla Pharmaceuticals during December 2009, following its 2008 purchase of 70% of the firm. The move bolsters Zydus's steady revenue stream from Simayla's South African presence.

To read the full article, please choose one of the following options: